Ming Z. Cheah

11 Hospital Drive
Singapore, 169610, Singapore

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide.

Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide.

Journal: Clinical epigenetics
Published: November 03, 2022

An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma.

An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma.

Journal: Science translational medicine
Published: October 19, 2022

A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.

A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.

Journal: American journal of hematology
Published: December 13, 2021

Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Correction to: Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Journal: Leukemia
Published: March 09, 2021

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma.

Journal: Leukemia
Published: May 21, 2020

Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphoma.

Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphoma.

Journal: Blood advances
Published: March 02, 2020

Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma.

Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma.

Journal: Blood cancer journal
Published: November 05, 2019

Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations.

Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations.

Journal: The Lancet. Oncology
Published: September 11, 2019

A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter study.

A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter study.

Journal: Scientific reports
Published: May 13, 2019

Successful therapeutic rechallenge after a severe episode of high dose methotrexate-induced choreoathetosis: A case report.

Successful therapeutic rechallenge after a severe episode of high dose methotrexate-induced choreoathetosis: A case report.

Journal: Molecular and clinical oncology
Published: November 29, 2018

Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK/T cell lymphoma.

Whole exome sequencing identifies recessive germline mutations in FAM160A1 in familial NK/T cell lymphoma.

Journal: Blood cancer journal
Published: June 26, 2018
Showing 1-11 of 11

Last Updated: 09/26/2026